Treatment of active secondary progressive multiple sclerosis with treosulfan: an open label pilot study

被引：0
|
作者：
Wiendl, H
Kieseier, BC
Weissert, R
Hartung, HP
Melms, A
Kueker, W
Weller, M
机构：
[1] Univ Wurzburg, Wurzburg, Germany
[2] Univ Dusseldorf, D-4000 Dusseldorf, Germany
[3] Hertie Inst Clin Brain Res, Tubingen, Germany
[4] John Radcliffe Hosp, Oxford OX3 9DU, England
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S181 / S181
页数：1
相关论文
共 50 条
  • [1] Treatment of active secondary progressive multiple sclerosis with treosulfan
    Wiendl, Heinz
    Kieseier, Bernd C.
    Weissert, Robert
    Mylius, Heidrun A.
    Pichlmeier, Uwe
    Hartung, Hans-Peter
    Melms, Arthur
    Kuker, Wilhelm
    Weller, Michael
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 (07) : 884 - 889
  • [2] Treatment of active secondary progressive multiple sclerosis with treosulfan
    H. Wiendl
    B. C. Kieseier
    R. Weissert
    H. A. Mylius
    U. Pichlmeier
    H.-P. Hartung
    A. Melms
    W. Kuker
    M. Weller
    [J]. Journal of Neurology, 2007, 254 : 884 - 889
  • [3] Safety and efficacy of treosulfan in 21 patients with active secondary progressive multiple sclerosis after treatment with mitoxantrone
    Deiss, A.
    Braeuninger, S.
    Wiendl, H.
    Buttmann, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 200 - 200
  • [4] Mitoxantrone in worsening secondary progressive multiple sclerosis: A prospective, open-label study
    Khatri, BO
    Wroblewski, M
    Kramer, J
    Dukic, M
    Poplar, A
    Anderson, AJ
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2006, 67 (01): : 55 - 65
  • [5] Oral fumaric acid esters for the treatment of active multiple sclerosis:: an open-label, baseline-controlled pilot study
    Schimrigk, S.
    Brune, N.
    Hellwig, K.
    Lukas, C.
    Bellenberg, B.
    Rieks, M.
    Hoffmann, V.
    Poehlau, D.
    Przuntek, H.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (06) : 604 - 610
  • [6] Siponimod for active secondary progressive multiple sclerosis
    Gaber, Tarek
    [J]. PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2021, 25 (02) : 4 - 5
  • [7] Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: a pilot study
    Besnier, DP
    Chabannes, D
    Mussini, JMG
    Dupas, B
    Esnault, VLM
    [J]. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2002, 18 (01) : 36 - 41
  • [8] Immunoadsorption patients with multiple sclerosis:: an open-label pilot study
    Moldenhauer, A
    Haas, J
    Wäscher, C
    Derfuss, T
    Hoffmann, KT
    Kiesewetter, H
    Salama, A
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (08) : 523 - 530
  • [9] Dimethyl fumarate treatment of primary progressive multiple sclerosis: results of an open-label extension study
    Talbot, Jacob
    Lundell, Henrik
    Marstrand, Lisbet
    Madsen, Camilla Gobel
    Hansen, Malene Bredahl
    Siebner, Hartwig Roman
    Sellebjerg, Finn
    Chow, Helene Hojsgaard
    Sondergaard, Helle Bach
    Sorensen, Per Solberg
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
  • [10] Open-label study of pirfenidone in patients with progressive forms of multiple sclerosis
    Bowen, JD
    Maravilla, K
    Margolin, SB
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (03) : 280 - 283
12345